Olimel N9

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Olimel N9, is a mixture of essential and non‑essential amino acids presented as a powder for oral use. It supports metabolic functions and protein synthesis in patients requiring nutritional supplementation.

GNH USA supplies Olimel N9 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Olimel N9 provides amino acid supplementation for conditions where protein turnover is increased or intake is insufficient. - Post‑operative recovery: helps maintain nitrogen balance and supports tissue repair. - Chronic kidney disease: assists in managing amino‑acid loss during dialysis. - Malnutrition or cachexia: contributes to improved nutritional status and lean‑body mass. - Severe burns or trauma: supplies essential building blocks for wound healing. - Inborn errors of metabolism: provides specific amino acids required for metabolic control.

Amino‑acid mixtures are generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional expulsion of the dose. - Diarrhea: loose stools, especially with rapid infusion. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Headache: mild tension‑type headache.

Serious or Rare Side Effects: - Hyperammonemia: elevated blood ammonia levels, requiring monitoring. - Allergic reaction: rash, itching, or urticaria. - Anaphylaxis: rare but severe systemic hypersensitivity. - Metabolic acidosis: disturbance in acid‑base balance. - Electrolyte imbalance: abnormal serum potassium or calcium levels. - Renal function deterioration: worsening kidney parameters in susceptible patients.

When prescribing Olimel N9, clinicians should consider patient‑specific factors and monitor relevant clinical parameters. - Renal impairment: adjust dosing and monitor serum creatinine. - Hepatic dysfunction: watch for signs of hyperammonemia. - Pregnancy and lactation: use only if clearly needed; benefits must outweigh risks. - Concomitant nutrition therapy: coordinate with total parenteral nutrition regimens. - Electrolyte disturbances: check serum electrolytes before and during therapy. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Olimel N9 may interact with other agents that affect nitrogen balance or renal handling of metabolites.

Major Interactions (Avoid): - High‑dose nitrogen‑containing supplements: may cause hyperammonemia. - Certain diuretics (e.g., furosemide): increase risk of electrolyte loss.

Moderate Interactions (Monitor Closely): - Antiepileptic drugs (e.g., valproate): may alter amino‑acid metabolism. - Antibiotics such as aminoglycosides: potential additive nephrotoxicity. - Insulin therapy: amino acids can stimulate insulin release, affecting glucose control. - Oral protein supplements: may lead to excess nitrogen intake. - Parenteral nutrition solutions: require compatibility checks.